Company overview
W. L. Gore & Associates specializes in fluoropolymer-based advanced materials, including expanded polytetrafluoroethylene (ePTFE) with customizable additives like catalysts and antimicrobials for pharmaceutical and life sciences applications. Gore Medical provides innovative devices that address complex medical challenges, enhancing patient outcomes through high-performance solutions. The company pioneers materials science for industries requiring durable, biocompatible components.
Gore is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include gore pharma materials, fluoropolymers life sciences, eptfe medical devices, gore medical solutions, advanced materials pharma.
Structured facts
- Website
- https://www.gore.com
- Markets served
- United States & Americas
- Keywords
- gore pharma materials, fluoropolymers life sciences, eptfe medical devices, gore medical solutions, advanced materials pharma
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What materials does Gore offer for pharmaceutical applications?
- Gore develops fluoropolymer materials like ePTFE, incorporating additives such as catalysts and antimicrobial agents into the microstructure for pharma and life sciences uses.
- Does Gore Medical comply with regulatory standards?
- Gore Medical focuses on quality-driven innovation for medical devices, empowering healthcare professionals with solutions designed to meet complex clinical needs and improve patient outcomes.
- What are Gore's global manufacturing capabilities?
- As a multinational company headquartered in Newark, Delaware, Gore operates worldwide, delivering advanced fluoropolymer solutions across industries including pharma and medical devices.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
